gliclazide has been researched along with Gangrene in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Gangrene: Death and putrefaction of tissue usually due to a loss of blood supply.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The onset of Type 2 diabetes is insidious and is usually recognized only 5-12 years after hyperglycaemia develops." | 1.30 | Accelerated complications in Type 2 diabetes mellitus: the need for greater awareness and earlier detection. ( Muggeo, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muggeo, M | 1 |
1 other study available for gliclazide and Gangrene
| Article | Year |
|---|---|
Accelerated complications in Type 2 diabetes mellitus: the need for greater awareness and earlier detection.
Topics: Amputation, Surgical; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic | 1998 |